Discovery of AS-0141, a Potent and Selective Inhibitor of CDC7 Kinase for the Treatment of Solid Cancers.

CDC7, a serine-threonine kinase, plays conserved and important roles in regulation of DNA replication and has been recognized as a potential anticancer target. We report here the optimization of a series of furanone analogues starting from compound 1 with a focus on ADME properties suitable for clinical development. By replacing the 2-chlorobenzene moiety in 1 with various aliphatic groups, we identified compound 24 as a potent CDC7 inhibitor with excellent kinase selectivity and favorable oral bioavailability in multiple species. Oral administration of 24 demonstrated robust in vivo antitumor efficacy in a colorectal cancer xenograft model. Compound 24 (AS-0141) is currently in phase I clinical trials for the treatment of solid cancers.

[1]  H. Sugimoto,et al.  Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent. , 2020, Journal of medicinal chemistry.

[2]  M. Sawa,et al.  Discovery of novel furanone derivatives as potent Cdc7 kinase inhibitors. , 2017, European journal of medicinal chemistry.

[3]  T. Bush,et al.  The optimization of aminooxadiazoles as orally active inhibitors of Cdc7. , 2013, Bioorganic & medicinal chemistry letters.

[4]  K. Swinger,et al.  Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195. , 2013, ACS medicinal chemistry letters.

[5]  S. Matthews,et al.  Crystal structure of human CDC7 kinase in complex with its activator DBF4 , 2012, Nature Structural &Molecular Biology.

[6]  Wei Xu,et al.  Discovery of XL413, a potent and selective CDC7 inhibitor. , 2012, Bioorganic & medicinal chemistry letters.

[7]  S. Yokoyama,et al.  Rational evolution of a novel type of potent and selective proviral integration site in Moloney murine leukemia virus kinase 1 (PIM1) inhibitor from a screening-hit compound. , 2012, Journal of medicinal chemistry.

[8]  Eric F. Johnson,et al.  Aminopyrimidinone cdc7 kinase inhibitors. , 2012, Bioorganic & medicinal chemistry letters.

[9]  M. Trotter,et al.  Molecular architecture of the DNA replication origin activation checkpoint , 2010, The EMBO journal.

[10]  A. Isacchi,et al.  Cdc7 kinase inhibitors: 5-heteroaryl-3-carboxamido-2-aryl pyrroles as potential antitumor agents. 1. Lead finding. , 2010, Journal of medicinal chemistry.

[11]  Richard Sainsbury,et al.  Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers. , 2010, The American journal of pathology.

[12]  K. Labib.  How do Cdc7 and cyclin-dependent kinases trigger the initiation of chromosome replication in eukaryotic cells? , 2010, Genes & development.

[13]  Hisao Masai,et al.  Eukaryotic chromosome DNA replication: where, when, and how? , 2010, Annual review of biochemistry.

[14]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[15]  A. Isacchi,et al.  Cell division cycle 7 kinase inhibitors: 1H-pyrrolo[2,3-b]pyridines, synthesis and structure-activity relationships. , 2009, Journal of medicinal chemistry.

[16]  H. Masai,et al.  Cdc7 as a potential new target for cancer therapy. , 2008, Drug news & perspectives.

[17]  Charlotta Lindvall,et al.  Cdc7-Dbf4 kinase overexpression in multiple cancers and tumor cell lines is correlated with p53 inactivation. , 2008, Neoplasia.

[18]  G. Warren,et al.  Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase. , 2008, Journal of medicinal chemistry.

[19]  R. Bosotti,et al.  Cdc7 kinase inhibitors: pyrrolopyridinones as potential antitumor agents. 1. Synthesis and structure-activity relationships. , 2008, Journal of medicinal chemistry.

[20]  K. Arai,et al.  Cdc7 kinase complex: A key regulator in the initiation of DNA replication , 2002, Journal of cellular physiology.

[21]  K. Arai,et al.  Human and Xenopus cDNAs encoding budding yeast Cdc7‐related kinases: in vitro phosphorylation of MCM subunits by a putative human homologue of Cdc7 , 1997, The EMBO journal.